Skip directly to content

CBC APOLOGIZES TO PFIZER CANADA AND RETRACTS ITS STORY, CONFIRMING ACCURACY OF EMERGEN-C VITAMIN C LABEL CLAIMS

21/01/16

January 21, 2016 - The CBC has retracted a Marketplace story it aired November 13, 2015 about the quality of EMERGEN-C and the level of vitamin C contained in the product.

In a statement to Pfizer Canada dated January 18, 2016, the CBC advised that following the original broadcast of its story on EMERGEN-C it received new information casting doubt on the reliability of the original testing, prompting it to request additional tests by a different lab. Subsequently, CBC issued a full retraction of its original report and apologized to Pfizer Canada: “Each of those [new] tests confirmed that the amount of vitamin C in the [EMERGEN-C] product fell within the acceptable range for label claims as permitted by Health Canada. As a result, the CBC will be broadcasting a full retraction and apology on all platforms where the original story aired.” (See below for the full letter.)

In all communications with CBC, including our original statement to Marketplace posted on their website, Pfizer Canada has steadfastly maintained its confidence in the quality of EMERGEN-C as well as its product testing methodologies.  As a manufacturer of prescription medicines and natural health products, Pfizer ensures these products are manufactured, packaged, tested and distributed with respect to the highest industry standards in order to maintain the highest level of quality and integrity. Consumers can continue to have full confidence in Pfizer and EMERGEN-C.

 

CBC letter to Pfizer Canada:

“We are writing in response to your various correspondence concerning the episode of Marketplace that initially aired on CBC on November 13, 2015 and associated coverage. In that correspondence, you took the position that the independent lab testing that had been commissioned by CBC showing [your] product did not contain the amount of vitamin C as claimed on the label was incorrect.

Since the episode went to air, CBC obtained information which caused it to doubt the reliability of the lab tests with which it was provided, and had three different batches of Pfizer’s Emergen-C tested by a different lab. Each of those tests confirmed that the amount of vitamin C in the product fell within the acceptable range for label claims as permitted by Health Canada. As a result, CBC will be broadcasting a full retraction and apology on all platforms where the original stories aired on January 22, 2016.”

 

-30-

 

Media Inquiries:
Pfizer Canada Inc.
1 866 9PFIZER (973-4937)